Jeff Garro
Stock Analyst at Stephens & Co.
(1.17)
# 3,787
Out of 5,124 analysts
57
Total ratings
35.9%
Success rate
-10.8%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CERT Certara | Maintains: Overweight | $15 → $12 | $8.81 | +36.21% | 6 | Dec 12, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $23.71 | +34.96% | 6 | Dec 4, 2025 | |
| OPRX OptimizeRx | Maintains: Equal-Weight | $20 → $17 | $12.26 | +38.66% | 4 | Nov 17, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $4.00 | +125.00% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $16.92 | +89.13% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $18.23 | +9.71% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $22.07 | +26.87% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $223.23 | +25.43% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $2.39 | +109.21% | 4 | Mar 6, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $2.88 | +73.61% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $55 | $44.28 | +24.21% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $225.41 | +10.91% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $19.04 | -10.71% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $7.00 | +300.00% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $19.75 | +1.27% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $5.19 | -24.86% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $1.41 | +112.77% | 3 | May 6, 2022 |
Certara
Dec 12, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $8.81
Upside: +36.21%
Privia Health Group
Dec 4, 2025
Reiterates: Overweight
Price Target: $32
Current: $23.71
Upside: +34.96%
OptimizeRx
Nov 17, 2025
Maintains: Equal-Weight
Price Target: $20 → $17
Current: $12.26
Upside: +38.66%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $4.00
Upside: +125.00%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $16.92
Upside: +89.13%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $18.23
Upside: +9.71%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $22.07
Upside: +26.87%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $223.23
Upside: +25.43%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.39
Upside: +109.21%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $2.88
Upside: +73.61%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $44.28
Upside: +24.21%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $225.41
Upside: +10.91%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $19.04
Upside: -10.71%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $7.00
Upside: +300.00%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $19.75
Upside: +1.27%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $5.19
Upside: -24.86%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $1.41
Upside: +112.77%